iShares U.S. Pharmaceuticals ETF (IHE)

ETF ยท NYSE Arca

iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund listed on NYSE Arca, where it has traded since May 1, 2006.

Type
Exchange-traded fund
Listed On
NYSE Arca
Listed Since
May 1, 2006

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 207 institutions reported holding IHE, with 7.3 million shares worth $727.4 million in aggregate. The largest reported holder was Fisher Asset Management, with 2.7 million shares worth $270.6 million. Of the 5 largest holders listed below, 3 added shares and 2 reduced their positions during the quarter.

InstitutionSharesValueQuarter change
Fisher Asset Management2,732,837$271MReduced 1.25%
Bank of America862,713$85MAdded 88.94%
JPMorgan Chase553,812$55MAdded 47.39%
Morgan Stanley457,623$45MReduced 4.72%
Lpl Financial230,925$23MAdded 35.69%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is IHE?

iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund listed on NYSE Arca, where it has traded since May 1, 2006.

Who are the largest institutional holders of IHE?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of IHE were Fisher Asset Management, Bank of America and JPMorgan Chase.

How many institutions own IHE?

207 institutions reported a position in IHE for the quarter ended June 30, 2026, worth $727.4 million in total.

Did institutions buy or sell IHE last quarter?

Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for IHE.

Every reported institutional holder, plus insider and congressional trades in IHE, on SentiSense.